Phase II Study of Fractionated 90Y Ibritumomab Tiuxetan (Zevalin) Radioimmunotherapy as an Initial Therapy of Follicular Lymphoma
Clinical trial NCT01493479 · COMPLETED
Trial details
- NCT number
- NCT01493479
- Sponsor
- The Christie NHS Foundation Trust
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-06-06
- Primary completion
- 2011-01-01
- Enrollment
- 76
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.